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Centrifuge chicken blood 
sample to collect plasma 
250 µl chicken plasma + 
750 µl ACN + C13DON (IS) 
Centrifuge 10’ at 8517g 
and 4°C 
Isolate supernatant and dry at 
70 °C under N2 
Reconstitute in 200 µl UPLC 
water and vortex 15” 
Filter (0.22 µm) 
and analyse 
Determination of the toxicokinetic parameters and degree of in vivo hydrolysis of 3ADON and 15ADON in broiler chickens. For this, an LC-MS/MS method needed to 
be developed and validated for the above mentioned compounds in chicken plasma. For sample clean-up, three methods were tested, a liquid-liquid extraction, a 
solid-phase extraction and a deproteinization by means of organic solvents. In the following steps of the development, critical factors (e.g. precipitation solvent, 
temperatures, etc ..) were examined by linear regression with the use of Plackett-Burman designs in order to determine their statistical significance.  
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INTRODUCTION 
The research towards the toxicity and occurrence of deoxynivalenol (and mycotoxins in general) has made significant 
progress. As the information and insight on native mycotoxins increases, the focus of this research domain tends to 
shift towards the gathering of occurrence and toxicity data on masked mycotoxins. These are mycotoxin conjugates or 
derivatives that are undetectable by conventional methods due to changes in their structural formation and 
physicochemical properties. For this study we focused on two important and frequently occurring masked forms of 
deoxynivalenol, 3-acetyldeoxynivalenol (3ADON) and 15-acetyldeoxynivalenol (15ADON), both precursors in the 
fungal biosynthesis of deoxynivalenol (DON). Conversion of these masked mycotoxins back to their native form by in 
vivo hydrolysis cannot be excluded. Consequently, this would imply an underestimation of the degree of 
contamination upon analysis. Deepoxy-deoxynivalenol (DOM-1) is the main in vivo metabolite, with highly reduced 
toxicity due to the removal of the epoxide function.  
OBJECTIVES 
METHOD DEVELOPMENT AND VALIDATION 
Linearity 
R² & GOF 
LOQ 
(ng/ml) 
LOD 
(ng/ml) 
Accuracy Within-day 
precision 
Between-day 
precision 
DON 0.9975 
13.2% 
1 
 
0.04 -5.4% 28.7% 17.6% 
3ADON 0.9989 
4.9% 
1  0.13 -28.4% 22.6% 41.2% 
15ADON 0.9986 
3.1% 
2 0.70 2.0% 6.0% 19.2% 
DOM-1 0.9987 
7.2% 
2 0.51 5.5% 14.3% 32.8% 
MS/MS instrument: TSQ Quantum Ultra triple quadrupole mass 
spectrometer  
HPLC instrument: Surveyor autosampler Plus and MS Pump Plus  
Column: Hypersil Gold (50 mm x 2.1 mm i.d., d.p.: 1.9 mm) 
MFa: UPLC water + 0.1% acetic acid 
MFb: UPLC grade methanol + 0.1 % acetic acid 
Column temperature: 60°C 
Injection volume: 10 µl 
Flow rate: 0.5 ml/min 
Run Time: 12 minutes 
Detection: MRM-mode 
With thanks to Ghent University for the funding (BOF-project) 
Presented at the 35th MYCOTOXIN WORKSHOP  
Ghent, Belgium 22 – 24 May 2013 
www.mytox.be 
0% 
10% 
20% 
30% 
40% 
50% 
60% 
70% 
80% 
90% 
100% 
0 min 1 1,1 5 5,1 8 8,1 9,1 9,2 12 
MF B 
MF A 
CONCLUSION 
Linearity: three calibration curves (3 x n=7) in plasma up to 200 ng/ml 
LOQ:  lowest concentration (n=6) with acceptable results for accuracy and precision 
LOD: calculated from S/N values from the LOQ samples (n=6) 
Precision: determined at three levels (LOQ, 50 and 100 ng/ml), values presented in 
table are for LOQ, values are listed as relative standard deviation, within day (n=6), 
between day (n=3x3) 
Accuracy: determined at three levels (LOQ, 50 and 100 ng/ml), values presented in 
table are for LOQ (n=6) 
Specificity: results not shown, tested by injection of blank sample, no interfering 
peaks 
Carry-over: results not shown, tested by injecting a 50/50 (v/v) mixture of both 
mobile phases after a 200 ng/ml spiked plasma sample, none of the compounds 
showed carry-over 
• Solid-phase extraction as well as liquid-liquid extraction gave comparable results to a simple deproteinization by means of acetonitrile.  
• The latter method was further developed and validated. 
• C13DON was well suited as internal standard for all the compounds included in the LC-MS/MS method. 
• The method will be used to determine toxicokinetic parameters (AUC, Cmax, tmax, bioavailability, …) of the compounds in broiler chickens. 
Matrix effect: results not shown, ion suppression was observed in plasma, demonstrating the need of matrix matched calibration curves 
 
